Question of the Day

Question of the Day – Wednesday April 12, 2017

Question: Valproic acid is often sued in the management of chronic seizure disorders and for bipolar disease as well as in the preventive management of migraine headaches. In which clinical circumstances has levocarnitine been proposed to manage overdoses of valproic acid?

View full post for answer.

Question of the Day – Monday April 10, 2017

Question: Listeriosis is caused by the Gram-positive organism, Listeria monocytogenes. This bacterium generally causes self limited and mild gastroenteritis. What is the disease profile often associated with Listeria monocytogenes infections in at risk populations (e.g. pregnant women, elderly people, immuno-compromised people, unborn babies, and neonates) with possible inadequate cell mediated immunity?

View full post for answer.

Question of the Day – Thursday March 30, 2017

Question: The reference cited below notes “Workers in industries where beryllium is present may be exposed to beryllium by inhaling or contacting beryllium in the air or on surfaces. Inhaling or contacting beryllium can cause an immune response that results in an individual becoming sensitized to beryllium.” How is beryllium used in industry?

View full post for answer.